AngioDynamics to Participate in 35th Annual J.P. Morgan Healthcare Conference
ALBANY, N.Y., Jan. 03, 2017 (GLOBE NEWSWIRE) -- AngioDynamics (NASDAQ:ANGO), a leading provider of innovative, minimally invasive medical devices for vascular access, surgery, peripheral vascular disease and oncology, announced today that Jim Clemmer, President and Chief Executive Officer and Michael Greiner, Executive Vice President and Chief Financial Officer, are scheduled to present at the 35th annual J.P. Morgan Healthcare Conference on January 10, 2017 at 8:00 p.m EST (5:00 p.m. PST) at the Westin St. Francis in San Francisco.
A live audio and/or webcast and subsequent archived replay of AngioDynamics' presentation may be accessed via the investor relations section of the Company's website under "Events & Presentations" at http://investors.angiodynamics.com/events.cfm. The replay will be available for 90 days after the event.
AngioDynamics Inc. is a leading provider of innovative, minimally invasive medical devices used by professional healthcare providers for vascular access, surgery, peripheral vascular
disease and oncology. AngioDynamics' diverse product lines include market-leading ablation systems, fluid management systems, vascular access products, angiographic products and accessories, drainage products, thrombolytic products and venous products. More information is available at www.AngioDynamics.com.
AngioDynamics and the AngioDynamics logo are trademarks and/or registered trademarks of AngioDynamics Inc., an affiliate or a subsidiary.
Investor Relations Contacts:
News Provided by Acquire Media
Close window | Back to top